Joop P. Aendekerk

Urinary Soluble CD163 and Disease Activity in Biopsy-Proven ANCA-Associated Glomerulonephritis

Joop P. Aendekerk, Sjoerd A.M.E.G. Timmermans, Matthias H. Busch et al. · Clinical Journal of the American Society of Nephrology · 2020 · 40 citations · Full text

Medicine, Nephrology, Pathology +17

CD163 and CD206 expression define distinct macrophage subsets involved in active ANCA-associated glomerulonephritis

Joop P. Aendekerk, William F. Jiemy, Elisabeth Raveling‐Eelsing et al. · Journal of Autoimmunity · 2022 · 19 citations · Full text

Medicine, Immunology, Pathology +17

Annexin A1 Is Associated with Adverse Clinical Outcomes in Patients with COVID-19

Matthias H. Busch, Sjoerd A.M.E.G. Timmermans, Joop P. Aendekerk et al. · Journal of Clinical Medicine · 2022 · 14 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Assessment of longitudinal serum neutrophil extracellular trap–inducing activity in anti-neutrophil cytoplasmic antibody–associated vasculitis and glomerulonephritis in a prospective cohort using a novel bio-impedance technique

Joop P. Aendekerk, Renée Ysermans, Matthias H. Busch et al. · Kidney International · 2023 · 14 citations · Full text

Life Sciences, Immunology, Nephrology +17

Adding low dose cyclophosphamide to rituximab for remission-induction may prolong relapse-free survival in patients with ANCA vasculitis: A retrospective study

Renée Ysermans, Matthias H. Busch, Joop P. Aendekerk et al. · Journal of Translational Autoimmunity · 2022 · 11 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15